Health care-associated infections such as Pseudomonas aeruginosa (PA) bacteremia pose a major 15 clinical risk for hospitalized patients, and efforts to limit them are a priority. The fitness pressures 16 accounting for PA virulence factors that facilitate bloodstream infections are unclear, as these 17 infections are presumed to be a "dead-end" and have no impact on transmission. Here, we used a 18 mouse model to show that PA spreads from the bloodstream to the gallbladder, where it replicates 19 to extremely high numbers. Bacteria in the gallbladder then seed the intestines and feces, leading 20 to transmission to uninfected cage-mate mice. The findings demonstrate that the gallbladder is 21 critical for spread of PA from the bloodstream to the feces during bacteremia, a process that 22 promotes transmission. 23 3 MAIN 24
8 in the fecal bacterial load compared to infected mice housed on normal bedding (Fig. 3C ). To further 164 verify that the observed fecal shedding of bacteremic mice was not a consequence of coprophagia, we 165 tested whether PA delivered by orogastric inoculation of bacteremic mice was detectable in feces. A PA 166 strain marked with a chromosomal gentamicin resistance cassette (PABL012GM) was administered by 167 oral gavage to mice systemically infected either 4 or 10 hours prior with PABL012lux (Fig. 3D ). The orally 168 administered strain could only be detected in the feces of two mice when administered 10 hours after 169 initial injection of PABL012lux (Fig. 3D ). Furthermore, this recovered population of PABL012GM was 170 1,000 times smaller than the fecal population of systemically delivered bacteria (PABL012lux) and had a 171 minimal contribution to the overall bacterial counts in the feces. Together, these experiments indicate 172 that bacteremic mice can shed substantial amounts of PA into their environment for prolonged periods 173 independent of mouse coprophagic ingestion.
175
Fecal PA is transmitted to uninfected mice 176 We next examined the consequences of such high levels of PA fecal excretion into the local 177 environment following bloodstream infection. Given that PA infections in BALB/c mice require invasive 178 administration of the bacteria, we hypothesized that uninfected mice would not develop any signs of an 179 active infection when co-housed with systemically infected cage-mates. In addition, the data presented 180 above suggested that the gastrointestinal (GI) tract of uninfected mice was impervious to the passage 181 of PA following orogastric inoculation, so we anticipated that ingestion of PA-laden feces would not 182 enable transmission of PA to cage-mate mice. Mice infected intravenously with PABL012lux (~8 x 105 183 CFU) were co-housed with uninfected mice, and both sets of mice were monitored daily for outward 184 signs of illness and fecal excretion of PA. Daily cage and water changes were performed to minimize 185 any potential environmental PA reservoirs. As hypothesized, no uninfected mice displayed any 186 outward signs of PA infection; however, we observed that approximately 60% of the uninfected mice 187 began to excrete PABL012lux (103 -104 CFU/g feces) by day 4, with peak fecal excretion by uninfected 188 mice on day 6 ( Fig. 3B ). This was followed by a steady decline in bacterial counts in the feces over the 189 remaining 4 days. Moreover, one uninfected mouse continued to shed PABL012lux at the end of the 190 experiment despite clearance from the originally infected animals suggesting that this mouse 191 9 maintained prolonged carriage of PA in the GI tract. These experiments revealed that PA shed by 192 systemically infected mice may facilitate transmission to uninfected co-housed mice that is detectable in 193 the feces.
194
We hypothesized that PABL012lux detected in the feces of uninfected mice came from ingestion 195 of contaminated fecal pellets shed by infected mice. This observation was somewhat surprising, given 196 our previous results demonstrating the negligible impact of bacterial inoculation by oral gavage (Fig.   197 3D). Likewise, previous work in mouse models demonstrated that PA cannot access the GI tract 198 through orogastric routes unless extremely high doses of bacteria (>107 CFU/mL drinking water) were 199 administered to antibiotic-treated animals depleted of GI microbiota14-16. We further investigated this 200 phenomenon by delivering both standard (6 x 106 CFU) and high doses (3 x 108 CFU) of media-grown 201 PABL012lux to mice by oral gavage. This type of inoculation resulted in no detectable PA in the feces at 202 24 hours ( Fig. 3G ). To test whether the material and microbes present in feces could facilitate PA 203 carriage, we homogenized PABL012lux-contaminated fecal pellets into a slurry and orogastrically 204 inoculated the slurry (2 x 105 CFU, maximum obtainable dose from pellets of  25 shedding mice) into 205 healthy mice. No bacteria could be detected in the feces of these mice at 24 hours post gavage (Fig. 
206
3H), indicating that the presence of contaminated fecal material is not sufficient to allow orally 207 administered PA to result in carriage. We therefore hypothesized that the nature of the fecal pellet in 208 some way facilitates this process. We suspect that the deeper portions of the pellet could enhance the 209 survival of anaerobic bacteria that promote PA carriage in the GI tract or that pellet architecture might 210 enable PA survival during passage through the acidic environment of the stomach. To address this, we 211 collected all fecal pellets shed daily from mice infected intravenously with PABL012lux (infectious doses 212 not determined but estimated to be significantly less than the orogastric doses described above) and 213 transferred only the contaminated fecal pellets to the cages of uninfected mice simultaneously with 214 daily cage and water changes. One uninfected mouse began to shed PABL012lux by day 4 and 215 additional mice by day 6 (103 -104 CFU/g feces, Fig. 3E , F). These findings confirm that exposure to PA 216 contained within fecal pellets is sufficient to facilitate transmission to uninfected animals and suggest 217 that these pellets in some manner facilitate this transmission. In summary, mice systemically infected 218 10 with PA are capable of contaminating their environment through fecal shedding, which in turn allows 219 transmission to naïve mice that have ingested the fecal pellets.
221
The gallbladder is crucial for fecal excretion of PA following bloodstream infection
222
Given the results of our STAMP analysis indicating that the population of PA excreted in the 223 feces was preceded by dramatic expansion in the gallbladder, we wondered what impact removal of the 224 gallbladder would have on this excretion. Wild-type, sham-surgery (peritoneum opened and repaired),
225
and cholecystectomized mice (n=5, 2 replicates) were infected with the standard dose (2 x 106 CFU) of 226 PABL012lux. Daily cage and water changes were performed to minimize any potential environmental 227 contamination. On day 1, 90% of the wild-type and 100% of the sham mice excreted high levels of 228 PABL012lux (between 106 and 108 CFU/g feces), whereas only 40% of the cholecystectomized mice 229 excreted any PABL012lux and at significantly lower levels (between 103 and 105 CFU/g feces). The
230
proportion of shedding mice in all groups decreased through day 7, but the wild-type and sham mice 231 continued to excrete higher levels of PA than cholecystectomized mice ( Fig. 3I , J, K). These results 232 indicate that the bacterial expansion of PA in the gallbladder is crucial for high levels of bacterial 233 excretion into the environment and may play a role in transmission.
235
Type III secretion dramatically impacts PA dissemination and injury to the gallbladder
236
We sought to determine whether the high numbers of PA observed in the gallbladder resulted in 237 damage to the epithelium of this organ and whether known PA virulence factors played a role in this 238 process. To do so, we examined gallbladders of infected animals for histologic and ultrastructural 239 evidence of injury. Gallbladders from mock-infected animals, having no visible bacteria in the lumen, 240 had a typical mucosal layer consisting of columnar epithelial cells with basal nuclei, extended microvilli, 241 and an intact lamina propria ( Fig. 4A, B) . In contrast, the mucosa of gallbladders from infected mice 242 displayed a general distortion of the cellular architecture characterized by large nuclei, widened tight 243 junctions, increased vacuoles, and disrupted lamina propria (Fig. 4A, B ). Disrupted microvillus 244 architecture, characterized by blunted, disordered, or absent microvilli, was observed at the epithelial 245 surface, especially in areas of close association with PA bacteria (Fig. 4B ). In mice infected with 246 PABL012lux, we also noted intermittent focal bacterial aggregates at the epithelial surface overlying 247 damaged columnar epithelial cells ( Fig. 4A, Pa) . Neutrophils were observed at both the basolateral 248 surface (arrows) of the epithelial layer and extravasating through it towards visible lumenal bacteria 249 (arrowhead) ( Fig. 4C ).
250
The type III secretion system (T3SS) is a major driver of virulence in PA and is known to 251 damage epithelial surfaces17,18 through direct injection of cytotoxic effector proteins. To assess the role 252 of the T3SS in expansion within the gallbladder and intestines, mice were infected with a T3SS mutant 253 (PABL012∆pscJlux) and monitored for disease progression. The T3SS mutant was absent from the liver, 254 gallbladder, and feces when infected at the standard wild-type dose (Fig. 5A, B ). In addition, the 255 PABL012∆pscJlux mutant phenotype could not be rescued by coinfection with wild-type PABL012lux ( Fig. 
256
5C), suggesting that any in vivo bottlenecks act directly on the bacteria. The attenuation of the T3SS 257 mutant could be overcome by increasing the infectious dose 100-fold ( Fig. 5A, B ). However, in contrast 258 to the mucosal damage observed with wild-type infection, no damage to the gallbladder epithelium was 259 observed at this higher dose ( Fig. 5D ). Thus, an intact T3SS is important for PA dissemination to the 260 gallbladder and subsequent fecal shedding, and results in damage to the gallbladder epithelium.
262
PA disseminates to the gallbladder and is shed in the feces following pneumonia 263 While PA is a frequent cause of bloodstream infections, it is also an important cause of 264 ventilator-associated pneumonia19 and previous studies have demonstrated that PA is capable of 265 escaping into the bloodstream during pneumonia20. Given our observations following direct inoculation 266 of PA into the bloodstream, we hypothesized that, following pneumonia, PA would disseminate to and 267 expand within the gallbladder. To determine whether gallbladder expansion and fecal shedding were 268 observed following PA pneumonia, 6 to 8-week old BALB/c mice were infected by intranasal inoculation 269 with PABL012lux (standard dose, 2 x 106 CFU) and monitored for 24 hpi. Infected mice displayed a 270 largely disseminated pattern of infection ( Fig. 1M ) and contained high numbers of bacteria in the liver, 271 gallbladder and feces (Fig. 1N ). These data indicate that following pneumonia PA also expands within 272 the liver and gallbladder, and is ultimately shed in the feces. Thus, the consequences of both 288 and identifying the gallbladder as the main driver of fecal excretion. Here, we show for the first time 289 that the same strategy is used by a non-enteric pathogen. Thus, migration of bacteria from the 290 bloodstream to the gallbladder and subsequently to the intestines may be a more universal bacterial 291 exit strategy than previously appreciated.
292
Systemic infections caused by opportunistic pathogens are often viewed as evolutionary and 293 ecological "dead-ends" in that they are disadvantageous for pathogen survival and thought to be 294 accidents that do not benefit the pathogen. Our work suggests that this paradigm does not apply to PA.
295
Once in the bloodstream, PA transits to the gallbladder, which it exploits as a protected replication 296 niche and uses to facilitate its own exit back into the environment via high levels of intestinal shedding.
297
Mutations that enhance this process may therefore be selected for during infections and become fixed 298 in the PA gene pool. Rather than being an ecological "dead-end," PA bloodstream infections may 299 instead serve as a transmission strategy ( Fig. 6 ).
300
The hosts in which PA undergoes selection for gallbladder expansion and fecal excretion are 301 less clear. PA naturally infects cows, dogs, cats, goats, and mink25,26, all of which have gallbladders27, 302 13 so our mouse model may have identified bacterial processes that evolved in these mammals.
303
Interestingly, several lines of evidence suggest that our findings may be applicable to humans. PA is 304 one of the top 5 pathogens isolated from bile in patients with cholecystitis28 and has been associated 305 with secondary sclerosing cholangitis, a dreaded complication of critical illness that involves the biliary 306 system of the liver29. In this context, it has been suggested that PA gains access to the biliary tree by 307 ascending from the duodenum via the common bile duct. However, it is conceivable that some of these 308 infections are secondary to transient occult PA bacteremia and arrive in the gallbladder via the liver. 
321
Our findings suggest that PA is remarkably well equipped for replication in the gallbladder. Bile 322 and bile salts have traditionally been viewed as toxic to bacteria44, but both laboratory-adapted and 323 clinically-derived PA strains expanded in the gallbladders of mice, and select strains grew ex vivo in bile 324 as well as in enriched medium. The mechanisms of bile resistance in PA are unknown; however, a role 325 for multidrug efflux pumps such as MexAB-OprM has been suggested45,46. Thus, bile exposure may 326 promote antibiotic resistance through increases in efflux pump expression, and transit through the 327 gallbladder may enhance excretion of drug-resistant PA. Hardy and colleagues suggested that LM 328 uses the lumen of the gallbladder to escape immune surveillance23, and it is possible that the immune-329 privileged nature of this organ provides a hospitable environment for PA replication as well. PA plays 330 14 an active role in trafficking to and expansion in the gallbladder, as these processes are much less 331 efficient in the absence of a functional T3SS. These findings suggest that, in addition to enhancing 332 virulence, the PA T3SS promotes gastrointestinal carriage and transmission.
333
In summary, this work is the first to identify bacterial expansion in the gallbladder by the 334 environmentally ubiquitous, non-enteric, opportunistic pathogen PA and suggests that the strategy of 335 hijacking the gallbladder as a protected site for bacterial expansion to facilitate high levels of fecal 336 excretion may be more widely utilized by bacterial species than previously thought. PA bacteremia 337 leads to gallbladder expansion and fecal excretion, challenging the clinical paradigm that bloodstream 338 infections are "dead-ends". If these findings are shown to be applicable to humans, a better 339 understanding of the gallbladder's role in fecal excretion will be critical to curbing MDR bacterial 340 transmission in the healthcare setting. Table   349 1.
350
Escherichia coli strain TOP-10 (Invitrogen) was used for cloning and E. coli strains S17. 
355
Antibiotics were used at the following concentrations: irgasan 5 µg/mL (irg), gentamicin 100 356 μg/mL (gm), carbenicillin 250 μg/mL 52, and tetracycline 75 μg/mL (tet) for PA and gentamicin 15 357 μg/mL, carbenicillin 50 μg/mL, and tetracycline 10 μg/mL for E. coli. For blue-white discrimination, 5-358 15 bromo-4-Chloro-3-Indolyl-D-Galactopyranoside (Xgal) was added to plates at a concentration of 80 359 μg/mL. Further details on the strains and plasmids used in this study can be found in Tables 1, 2 The plasmid pminiCTXnpt2lux53,54, was transformed into E. coli strain S17.1 λpir. Following 365 conjugation, the luciferase cassette was introduced into the chromosomal attB site of the PA strains 366 PAO1, PA14, PABL012 and PABL012∆pscJ, PABL002, PABL016, PABL017, PABL028, PABL030, 367 PABL041, PABL046, PABL049, PABL095, PABL107, PAC6, and S10 via integrase-mediated 368 recombination using previously defined approaches55 to generate luciferase-labeled strains (e.g.
369
PABL012lux). Bioluminescent bacteria were confirmed by imaging plates on the IVIS Lumina LTE ® in 370 vivo Imaging System.
371
The gentamicin resistance cassette, including its native promoter, was amplified from 372 pEX18.Gm56 with the primers Gm-pCTX_F-BamHI-2 and Gm-pCTX_R-EcoRI (Table 4 ). It was then 373 ligated into the multiple cloning site of pminiCTX-155 to generate the plasmid pminiCTX-1GM. As above, 374 the resulting plasmid was transformed into E. coli S17.1 λpir and, following conjugation, was introduced 375 into PABL012 to generate the strain, PABL012GM. The gentamicin resistance cassette in PABL012GM 376 was shown to have no impact on CFU recovery (data not shown).
377
The pminiCTX-1lacZ plasmid (gift from Stephen Lory, Harvard Medical School) was transformed 378 into E. coli strain SM10 λpir. Following conjugation, the lacZ gene was introduced into the attB site of 379 the strain PABL012 via integrase-mediated recombination using previously described approaches to 380 generate the strain, PABL012lacZ.
382
Generation of Type-3-Secretion-Deficient P. aeruginosa 383 Upstream and downstream fragments surrounding the pscJ gene were amplified from PAO1 genomic 384 DNA using the following primers: pscJ-5-1-HindIII, pscJ-5-2, pscJ-3-1, and pscJ-3-2 HindIII, where 385 pscJ-5-2 and pscJ-3-1 contain a 24 bp-overlapping linker sequence 386 16 (TTCAGCATGCTTGCGGCTCGAGTT) to generate an in-frame deletion of the pscJ gene (Table 4 ).
387
The integration proficient vector, pEXG257 was cut with HindIII, and the three fragments were ligated 388 using the New England Biolabs Gibson Assembly ® Cloning Kit. The resulting vector, pEXG2∆pscJ, 389 was verified by sequencing at the NuSeq facility at Northwestern University and transformed into E. coli 390 SM10 λpir. Following conjugation and allelic exchange with PABL012lux, whole-genome sequencing 391 was performed on strain PABL012∆pscJlux to confirm the mutation. 
412
Briefly, overnight cultures of PA were grown in 5 mL of MINS medium, diluted into fresh medium the 413 next day, and regrown to exponential phase prior to infections. Mice were restrained, and a 20-gauge blunt-end straight feeding needle (Pet Surgical, Sherman Oaks, CA) was used to gavage 50 µL of the 415 appropriate dose of PA directly into the stomachs of 6-to 8-week-old BALB/c mice. Again, inoculums 416 were confirmed by plating serial dilutions on LB agar. Organ harvesting and bacterial plating for CFU 417 enumeration was performed as described above. The STAMP protocol used here was similar to that described by Abel et al. and Zhang et al.9, 11 . Table   460 4 contains the sequences of all primers used in this protocol. The plasmid pminiCTXSTAMP used for 461 generating the tagged P. aeruginosa library was constructed as follows. The gentamicin resistance 462 cassette (~1032 bp) from pEX18.Gm56 was amplified with primers P80 and P11011, the latter of which is 463 degenerate and contains a string of 30 random bases (Table 4 ). The amplified product was inserted 464 into the EcoRI site of the integration proficient plasmid pminiCTX-155. The resulting plasmid, 465 pminiCTXSTAMP, was transformed into E. coli strain TOP-10 and selected with gentamicin. Plasmid
466
DNA was harvested and transformed into E. coli SM10 λpir. Following conjugation, pminiCTXSTAMP was 467 introduced into the attB site of the PA strain PABL012 via integrase-mediated recombination to 468 generate PABL012pool, and transconjugants were selected with tetracycline. After 10 of 10 tested 469 colonies were found to have a unique, correct insertion of pminiCTXSTAMP, the remaining colonies were 470 19 scraped off plates and pooled. After addition of 25% glycerol, the pooled library of PABL012 471 (designated "PABL012pool") was divided into aliquots and stored at -80˚C. The plasmid was stably 472 integrated for at least 20 hours without selection (Extended Data Fig. 5B ).
474
Calibration Curve for the STAMP Study
475
As described by Abel et al.11, the diversity of barcodes present in a subculture of tagged bacteria can 476 be used to calculate the size of the founding population of that subculture. We compared the 477 mathematically determined founding population sizes to those induced experimentally. Briefly, we 478 diluted three frozen aliquots of the PABL012pool library (A, B, C) (50 μL) 1:100 in MINS and grew with 479 shaking overnight at 37˚C. In the morning, cultures were diluted into fresh MINS medium and grown at 480 37˚C for 3 hours. Cells were harvested by centrifugation (13,000 x g, room temperature, 2 min) and 481 resuspended in PBS. A small portion of each serial dilution of each replicate was used to enumerate 482 total CFU, and the remainder was plated at 37˚C overnight. Following growth, all bacterial colonies 483 were scraped off using Falcon cell scrapers into 5 mL of PBS. Samples were concentrated by 484 centrifugation at 8,000 x g for 10 minutes and resuspended in 1 mL of PBS. Genomic DNA was 485 harvested from each sample using the Promega Maxwell 16 Instrument ® and the Cell DNA Purification
486
Kit. The tagged region that harbored the 30-bp barcode was amplified in triplicate from genomic DNA 487 using primer P47 and primers P48, P51-73 (Table 4 ). The PCR products were run on a 1% agarose 488 gel, pooled, extracted from the gel using Qiagen QIAquick ® gel extraction kit and quantified (Invitrogen 
491
Illumina) using custom sequencing primer P4911 (Table 4 ) with a mean cluster density of 8.6 x 105 ± 2.5 492 x 105. Reaper-15-065 was used to discard sequence reads with low quality (≤Q30) and to trim the 493 sequence following the barcode59. The trimmed sequences were clustered with QIIME (version 1.9.1) 494 using pick_otus.py with a sequence similarity threshold of 0.960,61. The resulting estimated founding 495 population sizes (Nb) were mathematically calculated from the frequency of each barcode as described Fig. 5B, 6B) , which revealed that the 511 maximum allelic frequency of any single barcode in the total population at both 14 and 24 hpi was 
524
An inoculum of barcoded PABL012pool was prepared and injected into mice as described above. At 14 525 and 24 hpi, mice were euthanized, and the lungs, liver, spleen, gallbladder, stomach, small intestine, 526 21 cecum, colon, and feces were harvested, weighed, homogenized in 1 mL of PBS, and plated for CFU 527 counts. For Nb´ analyses, 500 µL of samples from the lung, spleen, liver, gallbladder, stomach, small 528 intestine, cecum, colon, feces, and 250 µL of inoculum x 30 were independently spread on 100 x 15 529 mm Petri dishes containing LB with 5 µg/mL irgasan. Plates were grown at 37˚C overnight and 530 bacteria sequenced for barcode diversity as above. Nb values were calculated as described in the 531 previous section and adjusted using the calibration curve with an R script11 to estimate in vivo founding 532 population sizes (Nb´). When the number of recovered CFUs was below 100, Nb´ determination was 533 not performed. "Genetic distance" between the bacterial populations in two different organs was 534 estimated by comparing the barcode allelic frequencies of the two populations using the Cavalli-Sforza 535 chord distance method13 as described by Abel et al.11. Genetic relatedness (GR) was calculated as (1 536 genetic distance).
538

Genetic Relatedness (GR) Threshold Determination
539
Given that the 30 inoculum replicates (INOC30) were from the same original sample of PABL012pool and 540 therefore technically identical with the maximum possible experimentally determined GR, we averaged 541 the GR between inoculum samples at 14 and 24 hpi. We then used this value minus 2 standard 542 deviations to set the lower threshold for "high" levels of GR at  0.88. Given that barcode loss is 543 stochastic and that the dominant barcodes found in individual organs are unique to each mouse, we 544 determined inter-mouse (between mice) and intra-mouse (within a single mouse) GR between organs 545 at 14 and 24 hpi (Extended Data Fig. 4D, Figure 2B,D) . We averaged all the inter-mouse and intra-546 mouse GR values, which yielded a value of 0.41. This value was used to set the lower threshold for 547 "moderately high" GR (i.e. "moderately high" is GR values  0.41 and  0.88). Since populations of PA 548 in organs between mice (inter-mouse) were the least likely to be related, we averaged the GR values of 
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Bile Growth Assays 579 P. aeruginosa PABL012lux or PAO1lux were grown overnight in MINS medium, inoculated 1:8 into fresh 580 medium the following day and regrown to exponential phase. One milliliter of culture was pelleted, re-581 suspended in PBS, and the OD600 adjusted to 0.7. This culture was diluted 1:100 and inoculated in 582 23 triplicate into 180 µL of LB, PBS, MINS medium, or a 35-40% bile solution. To prepare the bile 583 solution, 6-to 12-week-old BALB/c mice were anesthetized and sacrificed by cervical dislocation.
584
Gallbladders were harvested intact and lanced to release bile contents. Gentle centrifugation was used 585 to pellet tissue contents, liberating free bile. Freshly harvested bile was diluted to 35-40% with PBS.
586
Following inoculation, cultures were grown with shaking at 37˚C for 24 hours. Samples were taken at 587 time 0, 4, and 24 hours, diluted, and plated to quantify CFU. 
603
The data that support the findings of this study are available from the corresponding author upon 609 Table 3 . Plasmids used in this study. 
610
845
(cecum), CO (colon), FE (feces). GR is impacted in large part by the low allelic frequency barcodes.
846
The relative allelic frequencies of the all unique barcodes in every organ of a representative mouse is 847 shown at (E) 14 hpi (n=4612) 
Inoculum Cecum (44) 43 expand to very high numbers. Bacteria released from the GB through the bile into the small intestine 904 become the principal source of P. aeruginosa excreted in the feces.
